This list is an analysis based on recent market events. It's not an investment recommendation.
About
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
The current price of PLRZ is $14.36 USD — it has decreased by -1.71% in the past 24 hours. Watch Polyrizon stock price performance more closely on the chart.
What is Polyrizon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Polyrizon stocks are traded under the ticker PLRZ.
Is Polyrizon stock price growing?▼
PLRZ stock has risen by +4.06% compared to the previous week, the month change is a +29.84% rise, over the last year Polyrizon has showed a +234.26% increase.
What is Polyrizon market cap?▼
Today Polyrizon has the market capitalization of 29.93M
What is Polyrizon revenue for the last year?▼
Polyrizon revenue for the last year amounts to 0 USD.
What is Polyrizon net income for the last year?▼
PLRZ net income for the last year is -3.34M USD.
How many employees does Polyrizon have?▼
As of July 10, 2026, the company has 2 employees.
In which sector is Polyrizon located?▼
Polyrizon operates in the Health & Wellness sector.
When did Polyrizon complete a stock split?▼
The last stock split for Polyrizon was on November 28, 2025 with a ratio of 1:6.